Archives rna-interference

by in
Entry Author Date Location
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Marina Biotech Shuffles Management Team, as RNAi Falls Out of Favor, Cash Runs Low 09/07/11 Seattle
AVI Starts Duchenne Trial 08/15/11 Seattle
Time to Cure Cancer or Stash Cash Under the Mattress? 08/15/11 National
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Merck Shuts Down RNAi Research Center in SF, Cutting 50 Jobs 07/29/11 San Francisco
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Marina Biotech Adds $6.9M 05/17/11 Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
Alnylam Responds to Tekmira Suit 04/06/11 Boston
AVI Biopharma Adds $30M 04/01/11 Seattle
RXi Buys Apthera, Names New CEO 03/31/11 Boston
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
Alnylam CEO: Tekmira Accusation of Trade Secret Misuse was a “Big Surprise” 03/18/11 Boston
Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon’s Warhorse Retires, & More Seattle-Area Life Sciences News 03/17/11 Seattle
Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets 03/16/11 Boston
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Marina Biotech Nabs $5.1M 02/10/11 Seattle
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars 01/28/11 National
EyeGate Adds $6M to Series D 01/06/11 Boston
Alnylam Lays Out 2015 Goals 01/06/11 Boston
AVI Partners With Karolinska 01/05/11 Seattle
Santaris Gets $14M From Pfizer 01/04/11 San Diego
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive 12/20/10 Seattle
AVI Names New CEO 12/13/10 Seattle
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Page 3 of 7 « previous page · next page »